medline.ch Dermatologie Psoriasis

	From Onset to Outcome: A Long-term Retrospective, Single centre Study of Guttate Psoriasis from Israel. Acta Derm Venereol Kassem R, Edri N, Barzilai A, Galili E, Lyakhovitsky A, Tzanani I, Handelsman A, Baum S, Pavlotsky F. PMID: 42183773 [PubMed - indexed for MEDLINE]
	Analysis of failure of long-term treatment with anti-IL-17A biologics for psoriasis: a cross-sectional study. Eur J Dermatol Dai X, Zhang C, Lu J, Du S, Xia J, Yin Z. PMID: 42183700 [PubMed - in process]
	Comparison of the predictive efficacy of traditional and novel obesity indices for risk of psoriasis: emerging promise for metabolic score for visceral fat and effect modification by diabetes. Eur J Dermatol Qin Y, Zhang W, Zhang G, Cui J, Lu H. PMID: 42183687 [PubMed - indexed for MEDLINE]
	Correction: Efficacy and safety of biologics in erythrodermic psoriasis: a systematic review and single-arm meta-analysis. Front Immunol Gao L, Shen L, Yan H, Liu X, Wang Y, Li X. PMID: 42183269 [PubMed - in process]
	Comparative Effectiveness of Four Biologics for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. Cureus Abdullah A, Polus L. PMID: 42181314 [PubMed]
	TNFR1-selective inhibition in psoriasis: Interpreting early clinical findings from a phase 1 trial. J Eur Acad Dermatol Venereol Sarikaya Solak S. PMID: 42179006 [PubMed - in process]
	Epidermal Growth Factor Receptor Pathway Is a Potential Biological Mechanism in Inflammatory Bowel Disease-Induced Psoriasis. J Gastroenterol Hepatol Tao K, Sun H, Li F, Chang Y, Tang T, Xu H. PMID: 42177912 [PubMed - as supplied by publisher]
	Maintenance of Response With Icotrokinra, a Targeted Oral Peptide, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Randomized Treatment Withdrawal in Adults From the Phase 3, ICONIC-LEAD Study. J Am Acad Dermatol Soung J, Cui Y, Bissonnette R, Lebwohl MG, González-Cantero Á, Pinter A, Rich P, Prajapati VH, Miller-Kassamali M, Cafone J, Jiang J, Li S, Yang YW, Pink AE. PMID: 42176706 [PubMed - as supplied by publisher]
	Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings. J Eur Acad Dermatol Venereol Warren RB, Gooderham M, Lain E, Bissonnette R, Huang YH, Ringuet J, Hoffmann M, Pinter A, Merola JF, Rubens JH, Fan D, Hsu MC, Li S, Yang YW, DeKlotz CMC, Song EJ. PMID: 42175814 [PubMed - as supplied by publisher]
	Pathogenesis of psoriasis and psoriatic arthritis: Insights from animal models and single-cell and spatial transcriptomic analyses of skin, synovium and entheses. Best Pract Res Clin Rheumatol Kemeness C, Garcia-Hernandez ML, Schandua H, Gupta R, Spangenberg A, Ritchlin C, Liao W. PMID: 42173724 [PubMed - as supplied by publisher]
	Novel post-translational modification learning signature reveals DPP3 promotes progression of psoriasis by enhancing inflammatory activation. Gene Ye Z, Gao B, Tang H, Zhu L. PMID: 42173459 [PubMed - as supplied by publisher]
	Frailty and risk of incident psoriasis: Prospective UK Biobank evidence with inflammatory, genetic, and proteomic analyses. Maturitas Deng P, Cao Z, Yan S, Lu J. PMID: 42173001 [PubMed - as supplied by publisher]
	Efficacy and Safety of Dual Targeted Therapy Using Biologics and Small Molecules for Psoriasis and Comorbidities: A Systematic Review. J Cutan Med Surg Bai JQA, Geng RSQ, Sood S, Yeung J, Mufti A. PMID: 42171386 [PubMed - as supplied by publisher]
	Correction: Association between Life's Essential 8 and psoriasis in US adults: a cross-sectional study. Front Med (Lausanne) Zhang J, Ren C, Qin Z, Zhu L, Jin Z, Yan Y, Pan X, Luan L. PMID: 42169792 [PubMed]
	Macrophages in Psoriasis: From Functional Heterogeneity to Metabolic Reprogramming and Novel Therapeutics. Exp Dermatol Liu Q, Wu Y, Tang J, Kuang Y. PMID: 42169458 [PubMed - indexed for MEDLINE]
	Generalized Pustular Psoriasis in Portugal: Expert Perspectives on Patient Journey, Diagnosis, Therapeutic Goals, and Healthcare Optimization. Acta Med Port Torres T, Roda Â, Magalhães C, Frade J, Cruz MJ, Guimarães MJ, Gonçalo M. PMID: 42165323 [PubMed - as supplied by publisher]
	Efficacy of glucagon-like peptide 1 analogues in psoriasis: A cohort study. JAAD Int Bar D, Pavlotsky F, Baum S, Barzilai A. PMID: 42164833 [PubMed]
	Clinical Efficacy and Safety Profile of Bimekizumab in Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Endocr Metab Immune Disord Drug Targets Moon S, Choi HY, Choi YJ, Shin S. PMID: 42163728 [PubMed - as supplied by publisher]
	Long-term adherence to adapted physical activity in patients with chronic inflammatory arthritis: Insights from a longitudinal observational study. PLoS One Gondouin H, Poussel M, Albuisson E, Temperelli M, Hily O, Moussu A, Chary-Valckenaere I, Loeuille D, Chenuel B, Allado E. PMID: 42160326 [PubMed - indexed for MEDLINE]
	Perioperative use of disease-modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritis. Cochrane Database Syst Rev Ponkilainen V, Karjalainen TV, Kuitunen I, Uimonen M, Johnston RV, Saarinen A, Whittle SL, Glennon V, Grobler L, Horrigan D, Cyril S, Buchbinder R. PMID: 42159164 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 27962

Seite 1 von 1399

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung